Myeloma Updates: High-Risk Smoldering, MRD, IVIG, and Maintenance | Natalie Callander, MD |

Описание к видео Myeloma Updates: High-Risk Smoldering, MRD, IVIG, and Maintenance | Natalie Callander, MD |

Dr. Natalie Callander from the University of Wisconsin discusses numerous studies that have been presented at ASH.

Link to ASH playlist on HTU: https://healthtree.org/blood-cancer/u...

ASH Abstracts: Phase 3 Study of Teclistamab (Tec) in Combination with Lenalidomide (Len) and Tec Alone Versus Len Alone in Newly Diagnosed Multiple Myeloma (NDMM) As Maintenance Therapy Following Autologous Stem Cell Transplantation (ASCT): Safety Run-in (SRI) Results from the Majestec-4/EMN30 Trial

Phase 3 Randomized Study of Daratumumab Monotherapy Versus Active Monitoring in Patients with High-Risk Smoldering Multiple Myeloma: Primary Results of the Aquila Study

#ASH24 #myeloma #mmsm #leusm

Follow HealthTree: https://linktr.ee/HealthTreeUniversity

Комментарии

Информация по комментариям в разработке

Похожие видео